KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹219 Cr | ₹177 Cr | ₹152 Cr | ₹161 Cr | ₹140 Cr |
What is the latest Total Current Liabilities ratio of KOPRAN ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹219 Cr |
Mar2023 | ₹177 Cr |
Mar2022 | ₹152 Cr |
Mar2021 | ₹161 Cr |
Mar2020 | ₹140 Cr |
How is Total Current Liabilities of KOPRAN Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹219 Cr | 23.48 | |
Mar2023 | ₹177 Cr | 16.75 | |
Mar2022 | ₹152 Cr | -5.66 | |
Mar2021 | ₹161 Cr | 14.73 | |
Mar2020 | ₹140 Cr | - |
Compare Total Current Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹762.4 Cr | 1% | -11.1% | -39.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 1% |
-11.1% |
-39.2% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses